|
Originally published In Press as doi:10.1074/jbc.M107532200 on October 2, 2001
J. Biol. Chem., Vol. 276, Issue 49, 45806-45812, December 7, 2001
Localization of Three Types of the Inositol 1,4,5-Trisphosphate
Receptor/Ca2+ Channel in the Secretory Granules and
Coupling with the Ca2+ Storage Proteins Chromogranins A and
B*
Seung Hyun
Yoo ,
Young Soo
Oh,
Moon Kyung
Kang,
Yang Hoon
Huh,
Seung Ho
So,
Hyung Seon
Park, and
Hee Yun
Park
From the National Creative Research Initiative Center for Secretory
Granule Research, Korea Advanced Institute of Science and Technology,
Yu Sung Gu, Dae Jeon, Korea 305-701
Received for publication, August 7, 2001, and in revised form, September 25, 2001
 |
ABSTRACT |
Although the role of secretory granules as the
inositol 1,4,5-trisphosphate (IP3)-sensitive
intracellular Ca2+ store and the presence of the
IP3 receptor (IP3R)/Ca2+ channel on
the secretory granule membrane have been established, the identity of
the IP3R types present in the secretory granules is not
known. We have therefore investigated the presence of different types of IP3R in the secretory granules of bovine adrenal
medullary chromaffin cells using immunogold electron microscopy and
found the existence of all three types of IP3R in the
secretory granules. To determine whether these IP3Rs
interact with CGA and CGB, each IP3R isoform was
co-transfected with CGA or CGB into NIH3T3 or COS-7 cells, and the
expressed IP3R isoform and CGA or CGB were co-immunoprecipitated. From these studies it was shown that all three
types of IP3R form complexes with CGA and CGB in the cells. To further confirm whether the IP3R isoforms and CGA and
CGB form a complex in the secretory granules the potential interaction between all three isoforms of IP3R and CGA and CGB was
tested by co-immunoprecipitation experiements of the mixture of
secretory granule lysates and the granule membrane proteins. The three
isoforms of IP3R were shown to form complexes with CGA and
CGB, indicating the complex formation between the three isoforms of
IP3R and CGA and CGB in the secretory granules.
Moreover, the pH-dependent Ca2+ binding
property of CGB was also studied using purified recombinant CGB, and it
was shown that CGB bound 93 mol of Ca2+/mol with a
dissociation constant (Kd) of 1.5 mM at
pH 5.5 but virtually no Ca2+ at pH 7.5. The high capacity,
low affinity Ca2+-binding property of CGB at pH 5.5 is
comparable with that of CGA and is in line with its role as a
Ca2+ storage protein in the secretory granules.
 |
INTRODUCTION |
The secretory granules of endocrine cells, neurons, and
neuroendocrine cells contain many hormones, ions, peptides and
proteins, including 40 mM Ca2+ and 1-2
mM chromogranins A and B in addition to high concentrations of hormones (1-6). The secretory granule contents are secreted to the
extracellular space and then into the bloodstream during exocytosis,
which is initiated by a sudden increase of intracellular Ca2+ concentration (7). In bovine adrenal medullary
chromaffin cells the secretory granules occupy ~10% of the total
cell volume (8), thereby storing a majority of the intracellular
Ca2+ of the cell in the secretory granules. Hence it
appears inevitable for the secretory granules to participate in the
control of intracellular Ca2+ concentrations.
Consistent with this notion, the secretory granules from adrenal
medullary chromaffin cells (9), pancreatic acinar cells (10), and the
goblet cells (11) were shown to release stored Ca2+ in
response to IP3.1
Using optical sectioning and fluorescent microscope techniques the
participation of granular Ca2+ in the control of
intracellular Ca2+ concentration has clearly been
demonstrated by measuring the Ca2+ concentrations of both
the intragranular milieu and of the cytoplasm that is immediately
adjacent to the secretory granules simultaneously (11). Moreover,
granular Ca2+ was shown to participate in the initiation of
exocytosis (12-15), underscoring the importance of granular
Ca2+ not only in the control of intracellular
Ca2+ concentrations but also in exocytotic processes.
Despite the importance of the IP3-sensitive intracellular
Ca2+ store role of secretory granules, the study of
IP3R/Ca2+ channels in the secretory granules
did not begin until the secretory granule Ca2+ storage
protein chromogranin A was shown to interact with several integral
secretory granule membrane proteins at pH 5.5, including the
IP3R/Ca2+ channel (16). Since then the
existence of type 3 IP3R (IP3R-3) in the
insulin-containing secretory granules of pancreatic -cells had been
reported (17) although this study was questioned later due to potential
cross-interaction of the IP3R-3-specific antibody used with
insulin crystals found in the secretory granules (18). Nevertheless,
the existence of IP3R/Ca2+ channels in the
secretory granules of insulin-containing pancreatic -cells (19) and
adrenal medullary chromaffin cells (20) has been confirmed. However the
identity of IP3R/Ca2+ channel types present in
the secretory granules is unknown. So far three types of
IP3R (IP3R-1, -2, and -3) are known to exist, and they interact with each other to form homotetrameric and/or heterotetrameric structures in the native state (21-24), thus forming a Ca2+ channel (25). Each type of
IP3R/Ca2+ channel is known to have a different
sensitivity to both IP3 and surrounding Ca2+
concentrations (26-32). The IP3 concentration dependence
of Ca2+ release of these three types has been shown to be
in the order of
IP3R-2>IP3R-1>IP3R-3, the type 2 being the most active and type 3 being the least active (27). Moreover,
the Ca2+ release property of these channels is shown to be
dependent on the surrounding Ca2+ concentrations; the
Ca2+ release via the IP3R-1 exhibited a
biphasic Ca2+ dependence whereas that of IP3R-3
did not exhibit a biphasic Ca2+ dependence (27-32).
Although the secretory granules of bovine adrenal chromaffin cells
contain 40 mM Ca2+, more than 99.9% of the
intragranular Ca2+ stays bound to intragranular proteins
chromogranins, thus leaving only 24 µM free
Ca2+ inside the granules (33). Such low concentrations of
intragranular free Ca2+ have also been found in mouse
pancreatic acinar cell (10), goblet cell (11), and mast cell (34). Of
the chromogranins, chromogranin A and chromogranin B are the two major
proteins in virtually all secretory granules of endocrine cells,
neurons, and neuroendocrine cells (1-6). For instance, CGA is the most abundant protein in the bovine adrenal medullary chromaffin cells (1-6), whereas CGB is the most abundant protein in human adrenal medullary chromaffin cells (35, 36). Further, CGA is known to bind 55 mol of Ca2+/mol with a Kd of 4 mM at the intragranular pH 5.5 and 32 mol of
Ca2+/mol with a dissociation constant
(Kd) of 2.7 mM at a near physiological
pH 7.5 (37). The high capacity, low affinity Ca2+ binding
property of CGA has been proposed to be responsible for the
IP3-sensitive Ca2+ store role of secretory
granules of bovine adrenal medullary chromaffin cells (9, 37).
We have previously demonstrated direct interaction between the
IP3R-1 and CGA and CGB using purified IP3R-1
(20). Furthermore, coupling of CGA and CGB with the IP3R-1
was shown to enhance the IP3-induced Ca2+
release through the IP3R-1/Ca2+ channel
reconstituted in the liposomes (38). In addition, the open probability
and mean open time of the IP3R-1/Ca2+ channel
were also shown to increase in the lipid bilayer as a result of coupled
CGA (39). We have therefore investigated in the present study the
identity of IP3R types that are present in the secretory
granules and the pH-dependent Ca2+-binding
property of CGB. Moreover, the potential interaction between each
IP3R type and the secretory granule Ca2+
storage proteins chromogranins A and B was also studied.
 |
EXPERIMENTAL PROCEDURES |
Antibodies--
Production of polyclonal anti-rabbit CGA and CGB
antibodies were raised against intact bovine CGA and recombinant CGB.
Monoclonal hemagglutinin (HA) antibody was from Roche Molecular
Biochemicals. IP3R peptides specific to the terminal 10-13
amino acids of type 1 (HPPHMNVNPQQPA), type 2 (SNTPHENHHMPPA), and type
3 (FVDVQNCMSR) were synthesized with a carboxyl-terminal cysteine, and
anti-rabbit polyclonal antibodies were raised. The polyclonal
anti-rabbit antibodies were affinity purified on each immobilized
peptide following the procedure described for the IP3R
antibody production (16). Monoclonal anti-bovine CGB antibody was
produced following a standard procedure.
Purification of IP3R Isoforms from
Cerebellum--
Purification of bovine type 1, 2, and 3 IP3R was carried out following the procedure described
previously (20) except that an isoform-specific antibody-coupled
immunoaffinity column was used in each case. The purified bovine
cerebellum IP3Rs bound ~300-320 pmol of
IP3/mg of protein as determined according to the published
method (21).
Immunocytochemical Localization of IP3R-1, -2, and -3 in Adrenal Chromaffin Cells--
Tissue samples from bovine adrenal
medulla were fixed for 2 h at 4 °C in PBS containing 0.1%
glutaraldehyde, 4% paraformaldehyde, and 3.5% sucrose. After three
washes in PBS, the tissues were postfixed with 1% osmium tetroxide on
ice for 2 h, washed three times, and stained en block
with 0.5% uranyl acetate, all in PBS. The tissues were then embedded
in Epon 812 after dehydration in an ethanol series. Ultrathin sections
were collected on Formvar/carbon-coated nickel grids, which were then
floated on drops of freshly prepared 3% sodium metaperiodate (40) for
30 min. The immunogold labeling procedure was modified from Spector
et al. (41) and the manufacturer's recommended protocol
(British Biocell International). After etching and washing, the grids
were placed on 50-µl droplets of solution A (phosphate saline
solution, pH 8.2, containing 4% normal goat serum, 1% bovine serum
albumin, 0.1% Tween 20, 0.1% sodium azide) for 30 min. Grids were
then incubated for 2 h at room temperature in a humidified chamber
on 50-µl droplets of each type-specific anti-rabbit IP3R
antibody appropriately diluted in solution B (solution A but with 1%
normal goat serum), followed by rinses in solution B. The grids were
reacted with 10-nm gold-conjugated goat anti-rabbit IgG diluted in
solution A. Controls for the specificity of IP3R immunogold
labeling included 1) omitting the primary antibody, and 2) replacing
the primary antibody with preimmune serum. After washes in PBS and
deionized water, the grids were stained with uranyl acetate (7 min) and
lead citrate (2 min), and were viewed with a Zeiss EM912 electron microscope.
Co-transfection and Co-immunoprecipitation of IP3R-2
or -3 and CGA or CGB--
The full-length cDNAs for bovine
IP3R type 2 (Y. S. Oh, M. K. Kang and S. H. Yoo,
GenBankTM accession no. AF402600) and type 3 (M. K.
Kang, Y. S. Oh, and S. H. Yoo, GenBankTM accession no.
AF402601) were subcloned into the vector pcDNA 3.1(+) and tagged
with HA to create recombinant plasmid pc-b2 and -b3. NIH3T3 and COS-7
cells, along with CGA expressing pCI-CGA (42) and CGB expressing
pCI-CGB (43) cells, were cultured in DMEM medium supplemented with 10%
fetal bovine serum. The pc-b2 or -b3 was co-transfected either into
NIH3T3 cells along with CGA expressing pCI-CGA, or into COS-7 cells
along with CGB expressing pCI-CGB. Expression of IP3R-2 or
IP3R-3 as well as CGA or CGB in NIH3T3 and COS-7 cells was
confirmed by Western blot analysis (not shown). The rest of the
co-immunoprecipitation experiments followed the procedure described for
the co-transfection and co-immunoprecipitation of IP3R-1
and CGA or CGB (20).
Co-immunoprecipitation of Three Isoforms of IP3R and
CGA and CGB from Secretory Granules of Bovine Adrenal Chromaffin
Cells--
To perform co-immunoprecipitation experiments, 20 µg of
secretory granule lysate proteins and 200 µg of secretory granule membrane proteins (16) were mixed first in 220 µl of the pH 5.5 buffer (20 mM sodium acetate, pH 5.5, 0.1 M
KCl, and 0.1% Triton X-100). The mixture was precleaned by incubating
with protein A-Sepharose for 1 h at 4 °C, followed by
centrifugation at 22,000 × g for 5 min.
Immunoprecipitation was carried out using the supernatant (~200 µl)
by incubating with 10 µl (1 µg/µl) of the polyclonal anti-rabbit
CGB antibody for 1 h at 4 °C. Then 15 µl of a 1:1 slurry of
protein A-Sepharose in the pH 5.5 buffer was added to the mixture and
incubated for 1 h. The complexes were pelleted by centrifugation
at 3,500 × g for 1 min, and the immunoprecipitate was
washed five times with the pH 5.5 buffer. The bound proteins were
separated on 7.5% SDS-polyacrylamide gels and subjected to immunoblot
analysis using each isoform-specific IP3R antibodies and
monoclonal CGB and polyclonal CGA antibodies.
Purification of Recombinant CGB and Ca2+ Binding
Study--
Recombinant bovine CGB was expressed in Escherichia
coli and purified as described (42). For the CGB Ca2+
binding study, purified recombinant CGB (5 mg) was coupled to 0.2 g of cyanogen bromide-activated Sepharose 4B according to the method
suggested by the manufacturer (Amersham Pharmacia Biotech). The amount
of CGB coupled to Sepharose 4B was determined by extracting by a strong
alkali treatment as described previously (20). Upon completion of the
coupling, it was estimated that 1 mg of CGB was coupled to 1 ml (wet
volume) of Sepharose 4B, and this was used for
45Ca2+ binding studies. The Ca2+
binding studies were carried out according to the procedure described for the Ca2+ binding to CGA (20).
 |
RESULTS |
Specificity of Isoform-specific IP3R
Antibodies--
To determine whether each IP3R antibody
interacts with each isoform-specific IP3R, the proteins
that interact with each isoform-specific IP3R antibody were
purified from bovine cerebellum using each isoform-specific
antibody-coupled immunoaffinity column (Fig. 1A). Visualization of the
purified proteins on an SDS-polyacrylamide gel showed proteins with
molecular sizes of 260-280 kDa (Fig. 1A); the proteins
purified by type 1 and type 3 specific antibodies were shown in a
~280-kDa region while the protein purified by the type 2-specific
antibody was shown in a ~260-kDa region, indicating that each
IP3R isoform-specific antibody interacted with different proteins in the 260-280 kDa range. These proteins were shown to bind
300-320 pmol of IP3/mg as determined by a method described previously (21), thus confirming them as IP3Rs.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 1.
SDS-polyacrylamide gel electrophoresis and
immunoblot analysis of purified IP3R isoforms.
IP3R isoforms purified from bovine cerebellum using each
isoform-specific antibody-coupled immunoaffinity column were separated
on a 7.5% SDS-polyacrylamide gel (30 ng/lane) and visualized with
silver-staining (A). The identical gels were also subjected
to immunoblot analysis using type 1, 2, and 3 specific IP3R
antibodies (B). Lane 1, type 1 IP3R;
lane 2, type 2 IP3R; lane 3, type 3 IP3R. Note that each type of IP3R reacted only
with its isoform-specific antibody.
|
|
To further determine whether each of the purified proteins interact
with only one isoform-specific IP3R antibody or not, the purified IP3Rs were separated on 7.5% SDS-polyacrylamide
gels and subjected to immunoblot analysis using each isoform-specific IP3R antibody. Results in Fig. 1B show that the
different IP3R isoform purified reacts only with the
IP3R antibody with which it is purified and not with other
isoform-specific IP3R antibodies, thus demonstrating the
isoform-specific nature of the IP3R antibodies used.
Subcellular Localization of IP3R-1, -2, and -3--
To
determine the subcellular location of each type of IP3R in
the adrenal medullary chromaffin cells, immunogold cytochemistry was
carried out with bovine adrenal medulla using each IP3R
type-specific antibody (Fig. 2,
A-C). As shown in Fig. 2A, the
IP3R type I (IP3R-1)-reacting gold particles
were localized in the secretory granules whereas none of the gold
particles was localized in the mitochondria. More than half of the gold
particles found in the secretory granules are localized in the
periphery of the secretory granules along the secretory granule
membrane, consistent with the known location of the IP3R on
the secretory granule membrane (20).

View larger version (65K):
[in this window]
[in a new window]
|
Fig. 2.
Immunogold localization with
affinity-purified IP3R type 1, 2, and 3 antibodies.
Bovine adrenal medullary chromaffin cells were immunolabeled for type
1, 2, and 3 IP3R (10 nm) with each isoform-specific
affinity-purified IP3R antibodies. Majority of the
IP3R-1 (A), IP3R-2 (B),
and IP3R-3 labeling (C) gold particles are
localized on or near the membrane region of the secretory granules
(SG). The gold particles are also localized in the
endoplasmic reticulum (rer) but not in the mitochondria
(M). Bar, 200 nm.
|
|
To further determine the presence of IP3R type 2 (IP3R-2) in the secretory granules, the
IP3R-2-specific antibody was used in the immunogold
cytochemistry (Fig. 2B). The IP3R-2-reacting gold particles were primarily localized on the secretory granule membranes whereas no gold particles were found in the mitochondria (Fig. 2B). In a similar study using IP3R type 3- (IP3R-3) specific antibody (Fig. 2C), the
IP3R-3-reacting gold particles were also shown to localize
in the secretory granules of bovine adrenal medullary chromaffin cells,
more than half of the gold particles localizing on the periphery of the
secretory granules (Fig. 2C).
In parallel control experiments that had been carried out either
without the primary antibody or with preimmune serum, virtually no gold
particles were found in the identical chromaffin cell tissues (not
shown), further demonstrating the specificity of the immunogold labeling.
To ensure that the IP3R antibodies react specifically with
the IP3R on the secretory granule membrane and that each
type-specific IP3R antibody react specifically with the
corresponding IP3R type, the secretory granule membrane
proteins from bovine adrenal medulla were separated on a 7%
SDS-polyacrylamide gel and subjected to immunoblot analysis using each
type-specific IP3R antibody (Fig. 3). The IP3R-1-specific
antibody reacted exclusively with a ~280-kDa secretory granule
membrane protein, suggesting that the IP3R-1 antibody used
in the present study specifically reacted with the IP3R-1
on the secretory granule membrane. Similarly, antibodies specific for
IP3R-2 and -3 also reacted with a ~260-kDa and a ~280-kDa protein, respectively, on the secretory granule membrane (Fig. 3), indicating that the IP3R antibodies used in the
present study specifically reacted with different IP3Rs on
the secretory granule membrane protein. Some of the type 2 IP3R appeared to be degraded as an ~83-kDa protein also
reacted with the antibody.

View larger version (65K):
[in this window]
[in a new window]
|
Fig. 3.
Immunoblot of the secretory granule integral
membrane proteins with each type-specific IP3R
antibody. 70 µg of secretory granule integral membrane proteins
from bovine adrenal medullary chromaffin cells were separated on a 7%
SDS-polyacrylamide gel and were probed with the same each type-specific
IP3R (IP3R-1, -2, and -3) antibodies used in
the immunogold cytochemical studies. 10 µg of integral membrane
proteins were visualized with Coomassie Blue staining (memb.
prot.), and the immunoblot results obtained with the
IP3R-1 (type 1), IP3R-2 (type 2), and
IP3R-3 (type 3) antibodies are shown. A 260-280-kDa
membrane protein specifically reacted with each IP3R
antibody.
|
|
Complex Formation between the IP3R-1, -2, and -3 and
Chromogranins A and B--
We have previously demonstrated the
physical interaction between the IP3R-1 and CGA and CGB
(24). However, the potential physical interactions between the
chromogranins and either the IP3R-2 or the
IP3R-3 have not been studied. Hence, to determine whether
the IP3R-2 and chromogranins A and B are physically linked in the cells, each type of IP3R and CGA or CGB were
co-transfected into NIH3T3 or COS-7 cells and co-immunoprecipitation
was carried out (Figs. 4 and
5). As shown in Fig. 4, A and
B, immunoprecipitation of the NIH3T3 cell extracts, which
had been co-transfected with IP3R-2 and CGA, by monoclonal
HA antibody and immunoblot analysis by CGA and HA antibodies (Fig.
4A) indicated the co-immunoprecipitation of the
IP3R-2 and CGA. Moreover, immunoprecipitation of the same cell extracts with CGA antibody and immunoblot analysis by CGA and HA
antibodies (Fig. 4B) also indicated the co-precipitation of
CGA and IP3R-2, demonstrating the complex formation between the IP3R-2 and CGA in the cell. Furthermore, in similar
experiments NIH3T3 cells were co-transfected with the
IP3R-3 and CGA to determine the complex formation between
the IP3R-3 and CGA. As shown in Fig. 4, C and
D, immunoprecipitation of the NIH3T3 cell extracts that had
been co-transfected with the IP3R-3 and CGA by monoclonal HA antibody and immunoblot analysis by CGA and HA antibodies (Fig. 4C) indicated the co-immunoprecipitation of the
IP3R-3 and CGA. Further, immunoprecipitation of the same
cell extracts with CGA antibody and immunoblot analysis by CGA and HA
antibodies (Fig. 4D) also indicated the co-precipitation of
CGA and IP3R-3, indicating the complex formation between
the IP3R-3 and CGA in the cell. Identical results were also
obtained with COS-7 cells.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 4.
Co-immunoprecipitation of CGA with
IP3R-2 or -3. A and B, protein
extracts from NIH3T3 cells, which had been cotransfected with HA-tagged
IP3R-2 and CGA were immunoprecipitated with monoclonal HA
antibody (mHA Ab). The immunoprecipitates were separated on
a 7.5% SDS gel and were immunoblotted with anti-CGA antibody
(CGA Ab) (upper panel) and mHA Ab (lower
panel), respectively (A). The same extracts were
immunoprecipitated with CGA antibody and immunoblotted with mHA Ab
(upper panel) and CGA antibody (lower panel)
(B). C and D, protein extracts from
NIH3T3 cells which had been cotransfected with HA-tagged
IP3R-3 and CGA were immunoprecipitated with monoclonal HA
antibody (mHA Ab). The immunoprecipitates were separated on
a 7.5% SDS-gel and were immunoblotted with anti-CGA antibody (CGA Ab)
(upper panel) and mHA Ab (lower panel),
respectively (C). Same extracts were immunoprecipitated with
CGA antibody and immunoblotted with mHA Ab (upper panel) and
CGA antibody (lower panel) (D). Preimmune IgG was
used as control antibody (lane 1). 260 kDa
IP3R-2 and 280 kDa IP3R-3 were
co-immunoprecipitated with 75 kDa CGA.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 5.
Co-immunoprecipitation of CGB with
IP3R-2 or -3. A and B, protein
extracts from COS-7 cells, which had been cotransfected with HA-tagged
IP3R-2 and CGB were immunoprecipitated with monoclonal HA
antibody (mHA Ab), and were immunoblotted with anti-CGB antibody (CGB
Ab) (upper panel) and mHA Ab (lower panel),
respectively (A). Same extracts were immunoprecipitated with
CGB antibody and immunoblotted with mHA Ab (upper) and CGB
antibody (lower) (B). C and
D, protein extracts from COS-7 cells, which had been
cotransfected with HA-tagged IP3R-3 and CGB were
immunoprecipitated with monoclonal HA antibody (mHA Ab), and were
immunoblotted with anti-CGB antibody (CGB Ab) (upper panel)
and mHA Ab (lower panel), respectively (C). The
same extracts were immunoprecipitated with CGB antibody and
immunoblotted with mHA Ab (upper) and CGB antibody
(lower) (D). Preimmune IgG was used as control
antibody (lane 1). 260 kDa IP3R-2 and 280 kDa
IP3R-3 were co-immunoprecipitated with 105 kDa CGB.
|
|
Similarly, immunoprecipitation of the COS-7 cell extracts, which had
been co-transfected with the IP3R-2 and CGB, by monoclonal HA antibody and immunoblot analysis by CGB and HA antibodies (Fig. 5A) indicated the co-precipitation of CGB and
IP3R-2. Immunoprecipitation of the same cell extracts with
CGB antibody and immunoblot analysis by IP3R-2 and CGB
antibodies (Fig. 5B) also indicated the co-precipitation of
CGB and IP3R-2, further demonstrating the complex formation between the IP3R-2 and CGB in the cell. Likewise,
immunoprecipitation of the COS-7 cell extracts that had been
co-transfected by the IP3R-3 and CGB by monoclonal HA
antibody and immunoblot analysis by CGB and HA antibodies (Fig.
5C) indicated the co-precipitation of CGB and
IP3R-3. Moreover, immunoprecipitation of the same cell extracts with CGB antibody and immunoblot analysis by
IP3R-3 and CGB antibodies (Fig. 5D) also
indicated the co-precipitation of CGB and IP3R-3, again
demonstrating the complex formation between the IP3R-3 and
CGB in native state. Again, identical results were also obtained with
NIH3T3 cells, further suggesting the universal nature of complex
formation between the IP3Rs and chromogranins A and B.
To further determine whether all three isoforms of IP3R
form complexes with CGA and CGB in the secretory granules of adrenal chromaffin cells, the mixture of secretory granule lysate proteins and
the granule membrane proteins of bovine adrenal chromaffin cells was
immunoprecipitated with polyclonal anti-rabbit CGB antibody. The
presence of each isoform-specific IP3R, along with CGA and CGB, in the immunoprecipitate was tested using each isoform-specific IP3R antibodies and monoclonal CGB and polyclonal CGA
antibodies (Fig. 6). As shown in Fig. 6,
immunoprecipitation of the secretory granule proteins by polyclonal
anti-rabbit CGB antibody precipitated all three types of
IP3R (A, type 1; B, type 2; C, type 3) in addition to CGA
and CGB, clearly demonstrating the complex formation between all three
types of IP3R and CGA and CGB in the secretory granules of
adrenal chromaffin cells.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 6.
Co-immunoprecipitation of all three isoforms
of IP3R and CGA with CGB in the secretory granule proteins
of bovine adrenal chromaffin cells. The mixture of 20 µg of
secretory granule lysate proteins and 200 µg of secretory granule
membrane proteins were immunoprecipitated with 10 µg of polyclonal
anti-rabbit CGB antibody, and the immunoprecipitates were analyzed by
immunoblotting for the presence of IP3R-1 (A),
-2 (B), and -3 (C) using each isoform-specific
antibodies, and polyclonal CGA and monoclonal CGB antibodies.
|
|
Ca2+ Binding to CGB--
Although the
pH-dependent low affinity, high capacity Ca2+
binding property of CGA has been determined before (37), the low affinity, high capacity Ca2+ binding property of CGB
remained to be determined. To determine the Ca2+ binding
property of CGB, we have first expressed bovine CGB in E. coli and obtained large amounts of purified recombinant CGB as
described (43). One of the difficulties of determining the Ca2+ binding property of CGB was its tendency to aggregate
in the presence of Ca2+ (44). To avoid the aggregation
problem, CGB was first coupled to Sepharose 4B before measuring its
Ca2+ binding property. As shown in Fig.
7A, Ca2+ binding
to the immobilized CGB showed drastically different
pH-dependent profiles. Large amounts of Ca2+
bound to CGB at the intragranular pH 5.5 and the Ca2+
binding profile indicated saturation as the free Ca2+
concentration increased. In contrast, there was virtually no Ca2+ binding to CGB at a near physiological pH 7.5. Scatchard analysis (45) of the binding result (Fig. 7B)
showed that CGB bound 93 mol of Ca2+/mol (1290 nmol of
Ca2+/mg) at pH 5.5 with a dissociation constant
(Kd) of 1.5 mM. Although another high
capacity, low affinity Ca2+-binding protein CGA is also
known to bind more Ca2+ at pH 5.5 than at pH 7.5 (37), the
drastic difference in the Ca2+ binding property of CGB at
the two pH levels is surprising. Given that the acidic pH is expected
to reduce ionic interaction between negatively charged acidic protein
CGB and positively charged calcium ions, the high capacity
Ca2+ binding to CGB at pH 5.5 appears to be due to the CGB
conformation at the acidic pH.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 7.
Binding of Ca2+ to chromogranin B
immobilized on Sepharose 4B and Scatchard analysis.
45Ca2+ binding to CGB coupled to Sepharose 4B
was measured at pH 5.5 and pH 7.5 and was analyzed according to
Scatchard (45). Buffers used were either 20 mM sodium
acetate, pH 5.5, 0.1 M KCl, or 20 mM Tris-HCl,
pH 7.5, 0.1 M KCl. A, binding to
45Ca2+ to CGB was measured as described
previously (37). Data are means ± S.E. of three representative
experiments at pH 5.5 ( ) and pH 7.5 ( ). B, Scatchard
analysis of the Ca2+ binding data at pH 5.5 in panel
A. Chromogranin B bound 1290 nmol of Ca2+/mg (93 mol
of Ca2+/mol) with a Kd of 1.5 mM at pH 5.5. B/F, bound/free.
|
|
 |
DISCUSSION |
Since the demonstration that the secretory granules of adrenal
medullary chromaffin cells release Ca2+ in response to
IP3 (9), the IP3-sensitive Ca2+
store role of secretory granules has also been shown in other secretory
cells (10, 11). The presence of IP3R on the secretory granule membrane has been shown in adrenal chromaffin cells (16, 20)
and pancreatic -cells (19). Further, the IP3R was
demonstrated to co-localize with chromogranin A in the secretory
granules of bovine adrenal medullary chromaffin cells (20).
Nevertheless, it was not known what isoforms of IP3R exist
on the secretory granule membrane. Present results demonstrate the
presence of all three types of IP3R in the secretory
granules of bovine adrenal medullary chromaffin cells (Fig. 2). By
co-transfection of IP3R-1 and CGA or CGB into COS-7 cells,
followed by co-immunoprecipitation of the expressed proteins, we have
shown previously that the IP3R-1 and CGA or CGB form
complexes in the cell (20). Likewise, co-transfection and
co-immunoprecipitation studies using the IP3R-2, -3 and
chromogranins A and B further demonstrated the complex formation
between CGA and the IP3R-2 or -3 (Fig. 4) and between CGB
and the IP3R-2 or -3 (Fig. 5). The complex formation
between the IP3Rs and chromogranins A and B appeared to be
an intrinsic property of these Ca2+ channel and
Ca2+ storage proteins, reflecting the functional coupling
in the secretory granules of secretory cells. It is hence of great
importance that the results in Fig. 6 clearly demonstrate that the
secretory granules of bovine adrenal chromaffin cells not only contain
all three isoforms of IP3R but also they form complexes
with CGA and CGB. This is the first time that chromogranins A and B
were shown to form complexes with all three isoforms of
IP3R in native state. The widespread presence of CGA and
CGB in the secretory granules of secretory cells appears to strongly
imply the physiological importance of the coupling between the
IP3Rs and the Ca2+ storage proteins in neurons,
endo/exocrine cells, and neuroendocrine cells.
In line with this importance, the coupling of CGA with the
IP3R was indeed shown to modulate the
IP3R/Ca2+ channel function (38). Using
liposomes incorporated with the purified IP3R-1 in the
presence and absence of encapsulated CGA, it was found that the coupled
CGA changed the conformation of IP3R-1 such that more
IP3 bound to the incorporated IP3R-1 and more
Ca2+ were released from the proteoliposomes in the presence
of coupled CGA (38). The IP3R/Ca2+ channel
modulatory role of CGA was observed only when the intraliposomal pH was
maintained at 5.5 (38), the intragranular pH at which the
IP3R and CGA remain coupled (16, 20). But when the
intraliposomal pH was changed to 7.5, CGA failed to exhibit any effect
(38) due to its dissociation from the IP3R/Ca2+
channel (16, 20). It was further shown that the open probability and
mean open time of the IP3R/Ca2+ channel were
markedly increased in the presence of coupled CGA as determined by
single channel recordings using lipid bilayers (39). But when CGA was
decoupled from the IP3R/Ca2+ channel by
changing the pH from 5.5 to 7.5, the mean open time and open
probability of the IP3R/Ca2+ channel returned
to the levels obtained in the absence of CGA (39).
In addition to the increased binding of IP3 and the
conformational change of the IP3R/Ca2+ channel
as a result of CGA coupling, our preliminary results also suggested
that the IP3 sensitivity of the
IP3R/Ca2+ channel increases at least 5-fold in
the presence of coupled CGA, i.e. 5-fold less
IP3 is needed to induce release of same amount of
Ca2+ in the presence of coupled CGA than in the
absence.2 Moreover, the
IP3R/Ca2+ channel modulatory effect of CGA was
also similarly exhibited by CGB.2 From these results it
appears that the coupled Ca2+ storage proteins CGA and CGB
directly modulate the IP3R/Ca2+ channel such
that not only the IP3-mediated Ca2+ release
property but also the IP3 sensitivity of the
IP3R/Ca2+ channels are altered. In light of the
fact that chromogranins are most abundant in the secretory granules, it
is likely that the secretory granules will be more sensitive to
IP3 than other organelles such as the ER and nucleus.
Interestingly, it has continuously been shown that despite the presence
of IP3R/Ca2+ channels in the nucleus (46, 47),
endoplasmic reticulum (21-32), and secretory granules, a given dose of
IP3 does not necessarily evoke a uniform release of
Ca2+ from these organelles (29). This difference in the
amount of Ca2+ released from each IP3 sensitive
store in response to a same concentration of IP3 is likely
to be influenced by the presence or absence of chromogranins inside the
IP3R/Ca2+-containing organelles.
In this regard, the example of different sensitivity of IP3
sensitive intracellular Ca2+ store to IP3 has
clearly been shown in the case of pancreatic acinar cell (10, 48, 49).
The pancreatic acinar cell is highly polarized that all the zymogen
granules are localized in the apical secretory granule region whereas
the endoplasmic reticulum and nucleus are localized in the basal region
of the cell (50). The ER-rich, nucleus-containing cytoplasmic area
encircles the apical granule region where the cluster of zymogen
granules is found. Due to this kind of highly polarized morphology of
pancreatic acinar cells, any IP3 that is produced at a
localized plasma membrane region away from the granule area should
travel through the ER-rich, nucleus-containing cytoplasm before it can
reach the secretory granule area. Indeed, exposure of pancreatic acinar
cells to the IP3-producing agonist such as acetylcholine
and cholecystokinin has been shown to release Ca2+ from the
secretory granule area first although the IP3-producing agonist was applied to the cell surface far removed from the secretory granule-rich area of the cell (10, 48, 49). Therefore, the release of
Ca2+ from the secretory granules of pancreatic acinar cell,
ahead of the ER and nucleus (10, 48, 49), clearly demonstrates the fact
that the secretory granules are more sensitive to IP3 than
the ER or the nucleus.
In line with the high capacity, low affinity Ca2+ binding
property of CGA at two different conformations (37), CGB also bound 93 mol of Ca2+/mol with a Kd of 1.5 mM at pH 5.5, but bound virtually no Ca2+ at pH
7.5 (Fig. 7). These results clearly point out a close relationship between the Ca2+ binding property and the conformation of
chromogranins A and B. Considering that binding of IP3 to
the IP3R/Ca2+ channel is known to change the
conformation of the IP3R/Ca2+ channel (51), it
is natural to assume that the conformational change of the
IP3R/Ca2+ channel that results from
IP3 binding will automatically be transmitted to the
coupled chromogranins, which in turn could lead not only to the change
in conformation of the chromogranins but also to the change in affinity
for Ca2+. This change in affinity for Ca2+ is
expected to change the free Ca2+ concentrations inside the
secretory granules instantaneously, probably changing from low to high
free Ca2+ concentrations. Therefore, given the large amount
of calcium (40 mM) in the secretory granule the sudden
dissociation of even a small fraction of the bound Ca2+
from the chromogranins is likely to produce a relatively high free
Ca2+ concentration that could be released into the
cytoplasm through the IP3R/Ca2+ channels. Given
the direct physical coupling between the
IP3R/Ca2+ channels and the Ca2+
storage proteins CGA and CGB in the secretory granules, the whole train
of events from the binding of IP3 to the release of
Ca2+ is expected to take place very fast, in accordance
with the fast stimulus secretion responses of secretory cells.
In light of the lack of other examples of direct coupling between an
ion channel and its cognate ion storage protein, the coupling between
the IP3R/Ca2+ channel and chromogranins A and B
stands out as the only known example of direct coupling between an ion
channel and its cognate ion storage protein. In particular, in view of
the fact that the IP3R/Ca2+ channel exists as
homo- and/or heterotetrameric structure (21-24) and that chromogranins
A and B can also exist either in homotetrameric CGA (52, 53) or in
heterotetrameric CGA2CGB2 structure (54), the
coupling between these two classes of proteins presents the possibility
of coupling between tetrameric IP3R/Ca2+
channel and tetrameric chromogranin (54). In this regard, the present
results demonstrating the complex formation between all three types of
IP3R/Ca2+ channels and chromogranins A and B in
the secretory granules further underscore this possibility. Given that
the IP3R/Ca2+ channels in the cell respond
differently even to same amount of IP3 (26-32) our present
results shed further light on the molecular structural basis of why the
IP3R/Ca2+ channels respond differently to a
given concentration of IP3 in the cell.
Although the ER also contains calreticulin, which is a high capacity,
low affinity Ca2+ storage protein (55), binding 25-50 mol
of Ca2+/mol with a Kd of 1-2
mM (56-58), it is not known whether calreticulin is
directly coupled to the IP3R/Ca2+ channel in
the ER. Calreticulin is estimated to represent 1-2% of total
microsomal proteins (57), whereas chromogranins A and B account for
more than 20% of the secretory granule proteins (1, 5). Moreover, the
total ER calcium concentration of ~3 mM (59) is far lower
than 40 mM Ca2+ in the secretory granules (1,
2, 33). Hence, these facts further highlight the need for cells to
better control the intracellular Ca2+ concentrations
through fine-tuning of the Ca2+ storage/release mechanisms
of the secretory granules. In this respect, the existence of all three
types of IP3R/Ca2+ channel and the abundant
presence of Ca2+ storage proteins chromogranins A and B in
the secretory granules will be pivotal for the secretory granules in
fine-tuning the intracellular Ca2+ concentrations in the
secretory cells.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF402600 and AF402601.
To whom correspondence should be addressed. Tel.: 82-42-869-8279;
Fax: 82-42-869-8280; E-mail: shyoo@kaist.ac.kr.
Published, JBC Papers in Press, October 2, 2001, DOI 10.1074/jbc.M107532200
2
S. H. Yoo and S. H. So, unpublished results.
 |
ABBREVIATIONS |
The abbreviations used are:
IP3, inositol 1,4,5-trisphosphate;
IP3R, inositol
1,4,5-trisphosphate receptor;
CGA, chromogranin A;
CGB, chromogranin B;
ER, endoplasmic reticulum;
HA, hemagglutinin;
PBS, phosphate-buffered
saline.
 |
REFERENCES |
| 1.
|
Winkler, H.,
and Westhead, E.
(1980)
Neuroscience
5,
1803-1823[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Hutton, J. C.
(1989)
Diabetologia
32,
271-281[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Simon, J.-P.,
and Aunis, D.
(1989)
Biochem. J.
262,
1-13[Medline]
[Order article via Infotrieve]
|
| 4.
|
Helle, K. B.
(1990)
Neurochem. Int.
17,
165-175[CrossRef]
|
| 5.
|
Winkler, H.,
and Fischer-Colbrie, R.
(1992)
Neuroscience
49,
497-528[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Iacangelo, A. L.,
and Eiden, L. E.
(1995)
Regulat. Pept.
58,
65-88
|
| 7.
|
Chen, Y. A.,
Scales, S. J.,
Duvvuri, V.,
Murthy, M.,
Patel, S. M.,
Schulman, H.,
and Scheller, R. H.
(2001)
J. Biol. Chem.
276,
26680-26687[Abstract/Free Full Text]
|
| 8.
|
Nordmann, J. J.
(1984)
J. Neurochem.
42,
434-437[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Yoo, S. H.,
and Albanesi, J. P.
(1990)
J. Biol. Chem.
265,
13446-13448[Abstract/Free Full Text]
|
| 10.
|
Gerasimenko, O. V.,
Gerasimenko, J. V.,
Belan, P. V.,
and Petersen, O. H.
(1996)
Cell
84,
473-480[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Nguyen, T.,
Chin, W.-C.,
and Verdugo, P.
(1998)
Nature
395,
908-912[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Maruyama, Y.,
Inooka, G.,
Li, Y. X.,
Miyashita, Y.,
and Kasai, H.
(1993)
EMBO J.
12,
3017-3022[Medline]
[Order article via Infotrieve]
|
| 13.
|
Maruyama, Y.,
and Petersen, O. H.
(1994)
Cell Calcium
16,
419-430[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Mundorf, M. L.,
Hochstetler, S. E.,
and Wightman, R. M.
(1999)
J. Neurochem.
73,
2397-2405[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Mundorf, M. L.,
Troyer, K. P.,
Hochstetler, S. E.,
Near, J. A.,
and Wightman, R. M.
(2000)
J. Biol. Chem.
276,
9136-9142
|
| 16.
|
Yoo, S. H.
(1994)
J. Biol. Chem.
269,
12001-12006[Abstract/Free Full Text]
|
| 17.
|
Blondel, O.,
Moody, M. M.,
Depaoli, A. M.,
Sharp, A. H.,
Ross, C. A.,
Swift, H.,
and Bell, G. I.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
7777-7781[Abstract/Free Full Text]
|
| 18.
|
Ravazzola, M.,
Halban, P. A.,
and Orci, L.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
2745-2748[Abstract/Free Full Text]
|
| 19.
|
Srivastava, M.,
Atwater, I.,
Glasman, M.,
Leighton, X.,
Goping, G.,
Caohuy, H.,
Miller, G.,
Pichel, J.,
Westphal, H.,
Mears, D.,
Rojas, E.,
and Pollard, H. B.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
13783-13788[Abstract/Free Full Text]
|
| 20.
|
Yoo, S. H.,
So, S. H.,
Kweon, H. S.,
Lee, J. S.,
Kang, M. K.,
and Jeon, C. J.
(2000)
J. Biol. Chem.
275,
12553-12559[Abstract/Free Full Text]
|
| 21.
|
Maeda, N.,
Niinobe, M.,
and Mikoshiba, K.
(1990)
EMBO J.
9,
61-67[Medline]
[Order article via Infotrieve]
|
| 22.
|
Monkawa, T.,
Miyawaki, A.,
Sugiyama, T.,
Yoneshima, H.,
Yamamoto-Hino, M.,
Furuich, T.,
Saruta, T.,
Hasegawa, M.,
and Mikoshiba, K.
(1995)
J. Biol. Chem.
270,
14700-14704[Abstract/Free Full Text]
|
| 23.
|
Joseph, S. K.,
Lin, C.,
Pierson, S.,
Thomas, A. P.,
and Maranto, A. R.
(1995)
J. Biol. Chem.
270,
23310-23316[Abstract/Free Full Text]
|
| 24.
|
De Smedt, H.,
Missiaen, L.,
Parys, J. B.,
Henning, R. H.,
Sienaert, I.,
Vanlingen, S.,
Gijsens, A.,
Himpens, B.,
and Casteels, R.
(1997)
Biochem. J.
322,
575-583
|
| 25.
|
Ferris, C. D.,
Huganir, R. L.,
Supattapone, S.,
and Snyder, S. H.
(1989)
Nature
42,
87-89
|
| 26.
|
Mak, D.-O. D.,
McBride, S.,
and Foskett, J. K.
(1999)
J. Biol. Chem.
274,
22231-22237[Abstract/Free Full Text]
|
| 27.
|
Miyakawa, T.,
Maeda, A.,
Yamazawa, T.,
Hirose, K.,
Kurosaki, T.,
and Iino, M.
(1999)
EMBO J.
18,
1303-1308[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Ramos-Franco, J.,
Fill, M.,
and Mignery, G. A.
(1998)
Biophys. J.
75,
834-839[Medline]
[Order article via Infotrieve]
|
| 29.
|
Taylor, C. W.
(1998)
Biochim. Biophys. Acta
1436,
19-33[Medline]
[Order article via Infotrieve]
|
| 30.
|
Bezprozvanny, I.,
Watras, J.,
and Ehrlich, B. E.
(1991)
Nature
351,
751-754[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Hagar, R. E.,
Burgstahler, A. D.,
Nathanson, M. H.,
and Ehrlich, B. E.
(1998)
Nature
396,
81-84[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Adkins, C. E.,
and Taylor, C. W.
(1999)
Curr. Biol.
9,
1115-1118[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Bulenda, D.,
and Gratzl, M.
(1985)
Biochemistry
24,
7760-7765[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Quesada, I.,
Chin, W.-C.,
Steed, J.,
Campos-Bedolla, P.,
and Verdugo, P.
(2001)
Biophys. J.
80,
2133-2139[Medline]
[Order article via Infotrieve]
|
| 35.
|
Hagn, C.,
Schmid, K. W.,
Firscher-Colbrie, R.,
and Winkler.
(1986)
Lab. Invest.
55,
405-411[Medline]
[Order article via Infotrieve]
|
| 36.
|
Gill, B. M.,
Barbosa, J. A.,
Dinh, T. Q.,
Garrod, S.,
and O`Connor, D. T.
(1991)
Regul. Pept.
33,
223-235[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Yoo, S. H.,
and Albanesi, J. P.
(1991)
J. Biol. Chem.
266,
7740-7745[Abstract/Free Full Text]
|
| 38.
|
Yoo, S. H.,
and Jeon, C. J.
(2000)
J. Biol. Chem.
275,
15067-15073[Abstract/Free Full Text]
|
| 39.
|
Thrower, E. C.,
Park, H. Y.,
Yoo, S. H.,
and Ehrlich, B.
(2001)
Biophys. J.
80,
455[Medline]
[Order article via Infotrieve].a
|
| 40.
|
Murphy, S. M.,
Pilowsky, P. M.,
and Llewellyn-Smith, I. J.
(1998)
J. Histochem. Cytochem.
46,
1261-1268[Abstract/Free Full Text]
|
| 41.
|
Spector, D. L.,
Fu, X. D.,
and Maniatis, T.
(1991)
EMBO J.
10,
3467-3481[Medline]
[Order article via Infotrieve]
|
| 42.
|
Kang, Y. K.,
and Yoo, S. H.
(1997)
FEBS Lett.
404,
87-90[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Yoo, S. H.,
and Kang, Y. K.
(1997)
FEBS Lett.
406,
259-262[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Yoo, S. H.
(1995)
J. Biol. Chem.
270,
12578-12583[Abstract/Free Full Text]
|
| 45.
|
Scatchard, G.
(1989)
Ann. N. Y. Acad. Sci.
51,
660-672[CrossRef]
|
| 46.
|
Matter, N.,
Ritz, M.-F.,
Freyermuth, S.,
Rogue, P.,
and Malviya, A.
(1993)
J. Biol. Chem.
268,
732-736[Abstract/Free Full Text]
|
| 47.
|
Gerasimenko, O. V.,
Gerasimenko, J. V.,
Tepikin, A. V.,
and Petersen, O. H.
(1995)
Cell
80,
439-444[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Thorn, P.,
Lawrie, A. M.,
Smith, P. M.,
Gallacher, D. V.,
and Petersen, O. H.
(1993)
Cell
74,
661-668[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Kasai, H.,
and Petersen, O. H.
(1994)
Trends Neurosci.
17,
95-101[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Kern, H. F.
(1993)
in
The Pancreas: Biology, Pathobiology and Disease
(Go, V. L. W., ed), 2nd Ed.
, pp. 9-19, Raven Press, New York
|
| 51.
|
Mignery, G. A.,
and Südhof, T. C.
(1990)
EMBO J.
9,
3893-3898[Medline]
[Order article via Infotrieve]
|
| 52.
|
Yoo, S. H.,
and Lewis, M. S.
(1992)
J. Biol. Chem.
267,
11236-11241[Abstract/Free Full Text]
|
| 53.
|
Thiele, C.,
and Huttner, W. B.
(1998)
J. Biol. Chem.
273,
1223-1231[Abstract/Free Full Text]
|
| 54.
|
Yoo, S. H.,
and Lewis, M. S.
(1996)
J. Biol. Chem.
271,
17041-17046[Abstract/Free Full Text]
|
| 55.
|
Johnson, S.,
Michalak, M.,
Opas, M.,
and Eggleton, P.
(2001)
Trends Cell Biol.
11,
122-129[CrossRef][Medline]
[Order article via Infotrieve]
|
| 56.
|
Ostwald, T. J.,
and MacLennan, D. H.
(1974)
J. Biol. Chem.
249,
974-979[Abstract/Free Full Text]
|
| 57.
|
Treves, S.,
De Mattei, M.,
Lanfredi, M.,
Villa, A.,
Green, N. M.,
MacLennan, D. H.,
Meldolesi, J.,
and Pozzan, T.
(1990)
Biochem. J.
271,
473-480[Medline]
[Order article via Infotrieve]
|
| 58.
|
Baksh, S.,
and Michalak, M.
(1991)
J. Biol. Chem.
266,
21458-21465[Abstract/Free Full Text]
|
| 59.
|
Meldolesi, J.,
and Pozzan, T.
(1998)
Trends Biochem. Sci.
23,
10-14[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Kang, J. Kang, H. Kwon, D. Frueh, S. H. Yoo, G. Wagner, and S. Park
Effects of Redox Potential and Ca2+ on the Inositol 1,4,5-Trisphosphate Receptor L3-1 Loop Region: IMPLICATIONS FOR RECEPTOR REGULATION
J. Biol. Chem.,
September 12, 2008;
283(37):
25567 - 25575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. Heidrich, K. Zhang, M. Estrada, Y. Huang, F. J. Giordano, and B. E. Ehrlich
Chromogranin B Regulates Calcium Signaling, Nuclear Factor {kappa}B Activity, and Brain Natriuretic Peptide Production in Cardiomyocytes
Circ. Res.,
May 23, 2008;
102(10):
1230 - 1238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-u. Choe and B. E. Ehrlich
The Inositol 1,4,5-Trisphosphate Receptor (IP3R) and Its Regulators: Sometimes Good and Sometimes Bad Teamwork
Sci. Signal.,
November 28, 2006;
2006(363):
re15 - re15.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Garcia, S.-K. Han, W. G. Janssen, Z. Z. Khaing, T. Ito, M. J. Glucksman, D. L. Benson, and S. R. J. Salton
A Prohormone Convertase Cleavage Site within a Predicted {alpha}-Helix Mediates Sorting of the Neuronal and Endocrine Polypeptide VGF into the Regulated Secretory Pathway
J. Biol. Chem.,
December 16, 2005;
280(50):
41595 - 41608.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E.-M. Hur, Y.-S. Park, Y. H. Huh, S. H. Yoo, K.-C. Woo, B.-H. Choi, and K.-T. Kim
Junctional membrane inositol 1,4,5-trisphosphate receptor complex coordinates sensitization of the silent EGF-induced Ca2+ signaling
J. Cell Biol.,
May 23, 2005;
169(4):
657 - 667.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-U. Choe, K. D. Harrison, W. Grant, and B. E. Ehrlich
Functional Coupling of Chromogranin with the Inositol 1,4,5-Trisphosphate Receptor Shapes Calcium Signaling
J. Biol. Chem.,
August 20, 2004;
279(34):
35551 - 35556.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. C. Thrower, C. U. Choe, S. H. So, S. H. Jeon, B. E. Ehrlich, and S. H. Yoo
A Functional Interaction between Chromogranin B and the Inositol 1,4,5-Trisphosphate Receptor/Ca2+ Channel
J. Biol. Chem.,
December 12, 2003;
278(50):
49699 - 49706.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. H. Huh, S. H. Jeon, and S. H. Yoo
Chromogranin B-induced Secretory Granule Biogenesis: COMPARISON WITH THE SIMILAR ROLE OF CHROMOGRANIN A
J. Biol. Chem.,
October 17, 2003;
278(42):
40581 - 40589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Thevenod
Ion channels in secretory granules of the pancreas and their role in exocytosis and release of secretory proteins
Am J Physiol Cell Physiol,
September 1, 2002;
283(3):
C651 - C672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Yoo, S. H. You, M. K. Kang, Y. H. Huh, C. S. Lee, and C. S. Shim
Localization of the Secretory Granule Marker Protein Chromogranin B in the Nucleus. POTENTIAL ROLE IN TRANSCRIPTION CONTROL
J. Biol. Chem.,
May 3, 2002;
277(18):
16011 - 16021.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|